IRF2 and breast cancer: EGR and NFkB (66) and SP1 in breast cancer (67) have been reported to induce the mRNA expression of IFNGR, while AP2 in breast cancer (67) and IRF2-mediated negative feedback in esophageal cancer (68) have suppressive roles.